1887
  1. Home
  2. A-Z Publications
  3. Global Cardiology Science and Practice
  4. Volume 2012, Issue 2
  5. Article
Volume 2012, Issue 2
  • ISSN: 2305-7823
  • EISSN:

Abstract

Abstract

In the management of coronary artery disease (CAD) it is important to ensure that all patients are receiving optimal medical therapy irrespective of whether any intervention, by stents or surgery, is planned. Furthermore it is important to establish if a proposed intervention is for symptomatic and/or prognostic reasons. The latter can only be justified if there is demonstration of a significant volume of ischaemia (>10% of myocardial mass). Taking together evidence from the most definitive randomized trial and its registry component (SYNTAX), almost 79% of patients with three vessel CAD and almost two thirds of patients with LMS disease have a survival benefit and marked reduction in the need for repeat revascularisation with CABG in comparison to stents, implying that CABG is still the treatment of choice for most of these patients. This conclusion which is apparently at odds with the results of most previous trials of stenting and surgery but entirely consistent with the findings of large propensity matched registries can be explained by the fact that SYNTAX enrolled ‘real life’ patients rather than the highly select patients usually enrolled in previous trials. SYNTAX also shows that for patients with less severe coronary artery disease there is no difference in survival between CABG and stents but a lower incidence of repeat revascularisation with CABG. At three years, SYNTAX shows no difference in stroke between CABG and stents for three-vessel disease but a higher incidence of stroke with CABG in patients with left main stem disease. In contrast the PRECOMBAT trial of stents and CABG in patients with left main stem disease showed no excess of mortality or stroke with CABG in comparison to stents in relatively low risk patients. Finally the importance of guidelines and multidisciplinary/heart teams in making recommendations for interventions is emphasised.

© 2012 Taggart, licensee Bloomsbury Qatar Foundation Journals.
Loading

Article metrics loading...

/content/journals/10.5339/gcsp.2012.20
2013-12-01
2024-11-13
Loading full text...

Full text loading...

/deliver/fulltext/gcsp/2012/2/gcsp.2012.20.html?itemId=/content/journals/10.5339/gcsp.2012.20&mimeType=html&fmt=ahah

References

  1. P Kolh, W Wijns, N Danchin, C DiMario, V Falk, T Folliguet, S Garg, K Huber, S James, J Knuuti, J Lopez-Sendon, J Marco, L Menicanti, M Ostojic, MF Piepoli, C Pirlet, JL Pomar, N Reifart, FL Ribichini, MJ Schalij, P Sergeant, Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), European Association for Percutaneous Cardiovascular Interventions (EAPCI). Guidelines on myocardial revascularization. Eur J Cardiothorac Surg. 2010; 38: Suppl: S1–S52Serruys PW, Silber S, SousaUva M, Taggart D
     [Google Scholar]
  2. DP Taggart, DG Altman, AM Gray, ART Investigators . , et al.. Randomized trial to compare bilateral vs. single internal mammary coronary artery bypass grafting: 1-year results of the Arterial Revascularisation Trial (ART). Eur Heart J. 2010; 31::2470–81
     [Google Scholar]
  3. MA Hlatky, DB Boothroyd, DM Bravata, E Boersma, J Booth, MM Brooks, et al.. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet. 2009; 373::1190–97
     [Google Scholar]
  4. A Jeremias, S Kaul, TK Rosengart, L Gruberg, DL Brown. The impact of revascularization on mortality in patients with nonacute coronary artery disease. Am J Med. 2009; 122::152–61
     [Google Scholar]
  5. K Stergiopoulos, DL Brown. Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease:meta-analysis of randomized controlled trials. Arch Intern Med. 2012; 172::312–19
     [Google Scholar]
  6. SJ Brener, BW Lytle, IP Casserly, JP Schneider, EJ Topol, MS Lauer. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation. 2004; 109::2290–95
     [Google Scholar]
  7. EL Hannan, MJ Racz, G Walford, RH Jones, TJ Ryan, E Bennett, AT Culliford, OW Isom, JP Gold, EA Rose. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med. 2005; 352::2174–83
     [Google Scholar]
  8. DJ Malenka, BJ Leavitt, MJ Hearne, JF Robb, YR Baribeau, TJ Ryan, RE Helm, MA Kellett, HL Dauerman, LJ Dacey, MT Silver, PN VerLee, PW Weldner, BD Hettleman, EM Olmstead, WD Piper, GT O'Connor, Northern New England Cardiovascular Disease Study Group . . Comparing long-term survival of patients with multivessel coronary disease after CABG or PCI: analysis of BARI-like patients in northern New England. Circulation. 2005; 112: 9: I371–76
     [Google Scholar]
  9. PK Smith, RM Califf, RH Tuttle, LK Shaw, KL Lee, ER Delong, RE Lilly, Sketch MH Jr. , ED Peterson, RH Jones. Selection of surgical or percutaneous coronary intervention provides differential longevity benefit. Ann Thorac Surg. 2006; 82::1420–28
     [Google Scholar]
  10. EL Hannan, C Wu, G Walford, AT Culliford, JP Gold, CR Smith, RS Higgins, RE Carlson, RH Jones. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med. 2008; 358::331–41
     [Google Scholar]
  11. C Wu, S Zhao, AS Wechsler, S Lahey, G Walford, AT Culliford, JP Gold, CR Smith, Holmes DR Jr. , King SB 3rd. , RS Higgins, D Jordan, EL Hannan. Long-term mortality ofcoronary artery bypass grafting and bare-metal stenting. Ann Thorac Surg. 2011; 92::2132–38
     [Google Scholar]
  12. WS Weintraub, MV Grau-Sepulveda, JM Weiss, SM O'Brien, ED Peterson, P Kolm, Z Zhang, LW Klein, RE Shaw, C McKay, LL Ritzenthaler, JJ Popma, JC Messenger, DM Shahian, FL Grover, JE Mayer, CM Shewan, KN Garratt, ID Moussa, GD Dangas, FH Edwards. Comparative effectiveness of revascularization strategies. N Engl J Med. 2012; 366::1467–76
     [Google Scholar]
  13. PW Serruys, MC Morice, AP Kappetein, SYNTAX Investigators . . Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009; 360::961–72
     [Google Scholar]
  14. AP Kappetein, TE Feldman, MJ Mack, et al.. Comparison of Coronary Bypass Surgery with Drug-eluting Stenting for the Treatment of Left Main and/or Three-vessel Disease: Three-year follow-up of the SYNTAX trial. Eur heart J. 2011; 32::2125–34
     [Google Scholar]
  15. SJ Park, YH Kim, DW Park, et al.. Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med. 2011; 364::1718–27
     [Google Scholar]
  16. EL Hannan, M Racz, DR Holmes, King SB 3rd. , G Walford, JA Ambrose, S Sharma, S Katz, LT Clark, RH Jones. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation. 2006; 113::2406–12
     [Google Scholar]
  17. DP Taggart, B Thomas. Ferguson Lecture. Coronary artery bypass grafting is still the best treatment for multivessel and left main disease, but patients need to know. Ann Thorac Surg. 2006; 82::1966–75
     [Google Scholar]
  18. DP Taggart. PCI or CABG in coronary artery disease?. Lancet. 2009; 37::1150–52
     [Google Scholar]
  19. J Booth, T Clayton, J Pepper, F Nugara, M Flather, U Sigwart, RH Stables, SoS Investigators . . Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS). Circulation. 2008; 118::381–88
     [Google Scholar]
  20. F Ribichini, D Taggart. Implications of new ESC/EACTS guidelines on myocardial revascularisation for patients with multi-vessel coronary artery disease. Eur J Cardiothorac Surg. 2011; 39::619–22
     [Google Scholar]
  21. DP Chandrasekharan, DP Taggart. Informed consent for interventions in stable coronary artery disease: problems, etiologies, and solutions. Eur J Cardiothorac Surg. 2011; 39::912–17
     [Google Scholar]
  22. PS Chan, MR Patel, LW Klein, RJ Krone, GJ Dehmer, K Kennedy, BK Nallamothu, WD Weaver, FA Masoudi, JS Rumsfeld, RG Brindis, JA Spertus. Appropriateness of percutaneous coronary intervention. JAMA. 2011; 306::53–61
     [Google Scholar]
/content/journals/10.5339/gcsp.2012.20
Loading
CABG in 2012: Evidence, practice and the evolution of guidelines
Global Cardiology Science and Practice 2012, 20 (2013); https://doi.org/10.5339/gcsp.2012.20
/content/journals/10.5339/gcsp.2012.20
/content/journals/10.5339/gcsp.2012.20
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): coronary artery bypass grafting, drug eluting stents, left main stem, multivessel coronary artery disease and SYNTAX trial
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error